BioLine RX Ltd (BLRX) — Capital Reinvestment Ratio
Latest as of December 2023:
0.00x
BioLine RX Ltd (BLRX) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow (ILA4.99 Million) in capital expenditures (ILA18.00K). See BioLine RX Ltd (BLRX) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
ILA4.99 Million
ILA
Capital Expenditures
ILA18.00K
ILA
Data as of
Dec 2023
Most recent filing
BioLine RX Ltd Capital Reinvestment Ratio (2010–2010)
This chart tracks BioLine RX Ltd's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for BioLine RX Ltd (2010–2010)
Year-by-year Capital Reinvestment Ratio for BioLine RX Ltd from 2010 to 2010. For live market cap and broader valuation context, see BioLine RX Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.06x | ILA11.46 Million | ILA660.94K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow